This finding is similar to the study of Leng et al. demonstrating that although a significant decrease in ophthalmology-related patient visit volume as a result of the COVID-19 pandemic was noted, it did not greatly impact age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion patients receiving intravitreal injections of anti-VEGF agents to stabilize and improve vision [16]. The gene discussed is VEGFA; the disease is macular retinal edema.